Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Phase 1 Completed
33 enrolled
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Phase 1/2 Completed
215 enrolled 30 charts
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer
Phase 1/2 Completed
51 enrolled
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Phase 1/2 Completed
23 enrolled
RECITE
Phase 3 Completed
165 enrolled 22 charts
A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface
Phase 1 Completed
67 enrolled
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
Phase 1 Completed
21 enrolled
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
Phase 1 Completed
42 enrolled
Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder
Phase 2 Completed
99 enrolled
LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)
Completed
130 enrolled
Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer
Phase 1 Completed
10 enrolled
LEAP-005
Phase 2 Completed
611 enrolled 27 charts
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors
Phase 1/2 Completed
332 enrolled 44 charts
GALAXY
Completed
799 enrolled
GLIMMER-01
Phase 1/2 Completed
69 enrolled 13 charts
OLAP
Completed
661 enrolled
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Completed
7 enrolled
TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Phase 1 Completed
185 enrolled 28 charts
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 Completed
23 enrolled
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Phase 1 Completed
56 enrolled 19 charts
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
Phase 1 Completed
46 enrolled
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Phase 1 Completed
185 enrolled
PROACC-1
Phase 2 Completed
187 enrolled 24 charts
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
Phase 1/2 Completed
89 enrolled 21 charts
MAESTRO
Phase 3 Completed
693 enrolled 8 charts
CLARITI
Completed
1,066 enrolled
VERIFI
Completed
386 enrolled
Study of XB002 in Subjects With Solid Tumors (JEWEL-101)
Phase 1 Completed
269 enrolled
BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients
Phase 2 Completed
45 enrolled 14 charts
PREFER
Completed
1,429 enrolled
Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma
Phase 1 Completed
54 enrolled
IT-01
Phase 1/2 Completed
111 enrolled 21 charts
LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Completed
44 enrolled
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901
Phase 1 Completed
176 enrolled
An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Modified FOLFIRINOX (mFFX) or Gemcitabine Plus Nab-paclitaxel (GnP) Therapy as First-line Treatment in Patients With Metastatic Pancreatic Cancer
Phase 1 Completed
46 enrolled
AMETHYST
Completed
2,325 enrolled
8479217
Phase 1 Completed
6 enrolled 17 charts
Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies
Completed
24 enrolled
A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
Phase 1/2 Completed
79 enrolled
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Phase 1/2 Completed
169 enrolled
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Phase 1 Completed
12 enrolled
A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)
Phase 1 Completed
95 enrolled
IVY
Phase 1 Completed
353 enrolled
A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors
Phase 1 Completed
190 enrolled
QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
Phase 1/2 Completed
138 enrolled 19 charts
PACT
Phase 1 Completed
164 enrolled
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors
Phase 1 Completed
73 enrolled 18 charts
Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer
Phase 2 Completed
28 enrolled 16 charts
CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma
Phase 1/2 Completed
50 enrolled
Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer
Phase 2 Completed
39 enrolled